Author

Liang Zhao

Johns Hopkins UniversityORCID 0000-0002-8992-2233Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Liang Zhao5 papers · University of North Carolina at Chapel Hill

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Assay:cryo-EM· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Alex S. BarasiD· 1 shared Andrés MatosoiD· 1 shared David James McConkeyiD· 1 shared Drew M. PardolliD· 1 shared Geetha Srikrishna· 1 shared Joy HuangiD· 1 shared Kara A. LombardoiD· 1 shared Max R. KatesiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alex S. BarasORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintDec 15, 2023

Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonist

Peter K. Um, Monali Praharaj, Kara A. Lombardo…·Trinity Jude Bivalacqua

This study evaluates a recombinant BCG strain that releases a STING agonist, showing improved antitumor efficacy in bladder cancer models compared to wild-type BCG.

10 citations

𝕏 PostBluesky